Xtant Medical Holdings (XTNT) Capital Expenditures (QoQ) (2010 - 2025)
Xtant Medical Holdings (XTNT) Capital Expenditures (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.65 Bn | 175.35 Bn | 6.27 Bn |
| 2 | Stryker | 128.95 Bn | 126.08 Bn | 3.81 Bn |
| 3 | Medtronic | 108.30 Bn | 99.08 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.31 Bn | 66.85 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.19 Bn | 44.52 Bn | 1.29 Bn |
| 6 | Dexcom | 28.33 Bn | 27.21 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.02 Bn | 25.74 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn |
| 10 | Xtant Medical Holdings | 61.00 Mn | 43.68 Mn | 17.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 17.49% |
| Jun 30, 2025 | -69.27% |
| Mar 31, 2025 | 77.23% |
| Dec 31, 2024 | -68.06% |
| Sep 30, 2024 | 273.05% |
| Jun 30, 2024 | -27.04% |
| Mar 31, 2024 | 112.95% |
| Dec 31, 2023 | 62.78% |
| Sep 30, 2023 | -46.14% |
| Jun 30, 2023 | -9.21% |
| Mar 31, 2023 | 2.93% |
| Dec 31, 2022 | -13.31% |
| Sep 30, 2022 | 56.75% |
| Jun 30, 2022 | -32.64% |
| Mar 31, 2022 | -22.68% |
| Dec 31, 2021 | 52.68% |
| Sep 30, 2021 | -23.65% |
| Jun 30, 2021 | -0.92% |
| Mar 31, 2021 | -15.05% |
| Dec 31, 2020 | 172.65% |